14-day Premium Trial Subscription Sign Up For FreeGet Free

Calithera Biosciences Stock Forecast NASDAQ:CALA

Price Target and Analyst Ratings

Most Recent Rating

On August 09, 2021 "HC Wainwright" gave "$4.00" rating for CALA. The price target was changed from $2.18 to 5.2%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-08-09 $4.00 Reiterated by HC Wainwright $2.22 $2.18→5.2%
2021-05-10 Buy Reiterated by HC Wainwright $1.96 $4.00
2021-01-05 Target Lowered by Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell $2.70 $10.00 → $5.00
2021-01-05 Target Lowered by Smith Barney Citigroup $2.70 $10.00 → $5.00
2021-01-05 Buy Target Lowered by HC Wainwright $2.70 $9.50 → $4.00
2021-01-05 Market Perform Downgraded by SVB Leerink $2.70 $7.00 → $2.00
2020-08-11 Outperform Target Lowered by SVB Leerink $4.16 $9.00 → $7.00
2020-06-02 Buy Reiterated by William Blair $5.71
2020-05-11 Buy Target Raised by Citigroup $6.84 $7.00 → $10.00
2020-05-08 Buy Reiterated by HC Wainwright $6.65 $7.00 → $9.50

CALA Stock Trend

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled.

Given the current short-term trend, the stock is expected to rise 17.07% during the next 3 months and, with a 90% probability hold a price between $2.47 and $3.00 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-09-30 $2.12 $2.34 $2.57
2021-10-01 $2.12 $2.35 $2.57
2021-10-04 $2.13 $2.35 $2.58
2021-10-05 $2.13 $2.36 $2.59
2021-10-06 $2.14 $2.37 $2.59
2021-10-07 $2.14 $2.37 $2.60
2021-10-08 $2.15 $2.38 $2.60
2021-10-11 $2.16 $2.38 $2.61
2021-10-12 $2.16 $2.39 $2.62
2021-10-13 $2.17 $2.40 $2.62
2021-10-14 $2.17 $2.40 $2.63
2021-10-15 $2.18 $2.41 $2.63
2021-10-18 $2.19 $2.41 $2.64
2021-10-19 $2.19 $2.42 $2.65
2021-10-20 $2.20 $2.42 $2.65
2021-10-21 $2.20 $2.43 $2.66
2021-10-22 $2.21 $2.44 $2.66
2021-10-25 $2.22 $2.44 $2.67
2021-10-26 $2.22 $2.45 $2.68
2021-10-27 $2.23 $2.45 $2.68
2021-10-28 $2.23 $2.46 $2.69
2021-10-29 $2.24 $2.47 $2.69
2021-11-01 $2.25 $2.47 $2.70
2021-11-02 $2.25 $2.48 $2.71
2021-11-03 $2.26 $2.48 $2.71
2021-11-04 $2.26 $2.49 $2.72
2021-11-05 $2.27 $2.50 $2.72
2021-11-08 $2.28 $2.50 $2.73
2021-11-09 $2.28 $2.51 $2.73
2021-11-10 $2.29 $2.51 $2.74

About Calithera Biosciences

Calithera Biosciences Calithera Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. Its lead product candidate includes CB-839, an inhibitor of glutaminase, which is in three Phase I clinical trials for the treatment of patients with solid tumors, leukemias, lymphomas, and multiple myelom... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT